BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24886180)

  • 1. Current evidences on XPC polymorphisms and gastric cancer susceptibility: a meta-analysis.
    Peng Q; Chen Z; Lu Y; Lao X; Mo C; Li R; Qin X; Li S
    Diagn Pathol; 2014 May; 9():96. PubMed ID: 24886180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. XPC Lys939Gln polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
    Peng Q; Lao X; Tang W; Chen Z; Li R; Qin X; Li S
    Diagn Pathol; 2014 Jun; 9():120. PubMed ID: 24947936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between XPC Lys939Gln gene polymorphism and urinary bladder cancer susceptibility: a systematic review and meta-analysis.
    Dou K; Xu Q; Han X
    Diagn Pathol; 2013 Jul; 8():112. PubMed ID: 23819639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of XPC Polymorphisms with Cutaneous Malignant Melanoma Risk: Evidence from a Meta-Analysis.
    Asadian F; Niktabar SM; Ghelmani Y; Kargar S; Akbarian E; Emarati SA; Sadeghizadeh-Yazdi J; Neamatzadeh H
    Acta Medica (Hradec Kralove); 2020; 63(3):101-112. PubMed ID: 33002396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-analysis.
    Peng Q; Lu Y; Lao X; Chen Z; Li R; Sui J; Qin X; Li S
    Diagn Pathol; 2014 May; 9():100. PubMed ID: 24884893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of the XPC gene may contribute to the risk of head and neck cancer: a meta-analysis.
    Zhang Y; Li Z; Zhong Q; Zhou W; Chen X; Chen X; Fang J; Huang Z
    Tumour Biol; 2014 Apr; 35(4):3917-31. PubMed ID: 24338715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. XPC gene polymorphisms contribute to bladder cancer susceptibility: a meta-analysis.
    Dai QS; Hua RX; Zeng RF; Long JT; Peng ZW
    Tumour Biol; 2014 Jan; 35(1):447-53. PubMed ID: 23918308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of associations between XPC polymorphisms and colorectal cancer: a meta-analysis.
    Wang G; Sun H; Liu Z; Huang R; Chen Y; Tang Q; Yu L; Jiang Z; Wang X
    J BUON; 2015; 20(3):770-4. PubMed ID: 26214629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analysis of evidences on XPC polymorphisms and lung cancer susceptibility.
    Liu C; Yin Q; Hu J; Li L; Zhang Y; Wang Y
    Tumour Biol; 2013 Apr; 34(2):1205-13. PubMed ID: 23381646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between polymorphisms of the XPC gene and lung cancer susceptibility: a meta-analysis.
    Zhu ML; Hua RX; Zheng L
    Tumour Biol; 2014 Apr; 35(4):2931-9. PubMed ID: 24375193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and breast cancer risk: a meta-analysis.
    Peng Q; Lu Y; Lao X; Chen Z; Li R; Sui J; Qin X; Li S
    Diagn Pathol; 2014 Jun; 9():108. PubMed ID: 24893568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XPC Lys939Gln and Ala499Val polymorphisms in colorectal cancer susceptibility: a meta-analysis of case-control studies.
    Liu C; Yin Q; Ying M; Lin J; Li L; Jiao G; Wang M; Wang Y
    Mol Biol Rep; 2014 Feb; 41(2):1171-8. PubMed ID: 24385304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of XPC polymorphisms and lung cancer risk: a meta-analysis.
    Jin B; Dong Y; Zhang X; Wang H; Han B
    PLoS One; 2014; 9(4):e93937. PubMed ID: 24736739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
    Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current evidences on XPC polymorphisms and breast cancer susceptibility: a meta-analysis.
    Zheng W; Cong XF; Cai WH; Yang S; Mao C; Zou HW
    Breast Cancer Res Treat; 2011 Aug; 128(3):811-5. PubMed ID: 21318603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione S-transferase M1 null genotype meta-analysis on gastric cancer risk.
    Meng X; Liu Y; Liu B
    Diagn Pathol; 2014 Jun; 9():122. PubMed ID: 24948179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An association between XPC Lys939Gln polymorphism and the risk of bladder cancer: a meta-analysis.
    Zhang Y; Wang X; Zhang W; Gong S
    Tumour Biol; 2013 Apr; 34(2):973-82. PubMed ID: 23269608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of DNA repair gene XPC Ala499Val (rs2228000 C>T) and Lys939Gln (rs2228001 A>C) polymorphisms with the risk of chronic myeloid leukemia: A case-control study in a South Indian population.
    Lakkireddy S; Aula S; Kapley A; Gundeti S; Kutala VK; Jamil K
    J Gene Med; 2021 Jul; 23(7):e3339. PubMed ID: 33829606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between CCND1 and XPC polymorphisms and bladder cancer risk: a meta-analysis based on 15 case-control studies.
    Wang Y; Li Z; Liu N; Zhang G
    Tumour Biol; 2014 Apr; 35(4):3155-65. PubMed ID: 24264314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly (AT) deletion/insertion polymorphism of the XPC gene contributes to urinary system cancer susceptibility: a meta-analysis.
    Dai QS; Hua RX; Zhang R; Huang YS; Hua ZM; Yun CT; Zeng RF; Long JT
    Gene; 2013 Oct; 528(2):335-42. PubMed ID: 23892089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.